These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28160072)

  • 1. Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.
    Dall'Ara F; Lazzaroni MG; Antonioli CM; Airò P
    Rheumatol Int; 2017 May; 37(5):847-851. PubMed ID: 28160072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Yoshizaki A; Miyazaki M; Tamaki Z; Sato S
    J Dermatol; 2016 Jul; 43(7):808-10. PubMed ID: 26876001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis.
    Lazzaroni MG; Campochiaro C; Bertoldo E; De Luca G; Caimmi C; Tincani A; Franceschini F; Airò P
    Clin Exp Rheumatol; 2021; 39 Suppl 131(4):25-28. PubMed ID: 33337991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Silicone Breast Implants, Breast Cancer and Anti-RNA Polymerase III Autoantibodies in Systemic Sclerosis: Case-Based Review.
    De Angelis R; Di Battista J; Smerilli G; Cipolletta E; Di Carlo M; Salaffi F
    Open Access Rheumatol; 2020; 12():207-213. PubMed ID: 33061688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
    Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
    J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
    Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
    J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
    Moinzadeh P; Fonseca C; Hellmich M; Shah AA; Chighizola C; Denton CP; Ong VH
    Arthritis Res Ther; 2014 Feb; 16(1):R53. PubMed ID: 24524733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
    Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
    Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.
    Cavazzana I; Ceribelli A; Airo' P; Zingarelli S; Tincani A; Franceschini F
    Autoimmun Rev; 2009 Jun; 8(7):580-4. PubMed ID: 19393210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
    Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
    J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
    J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
    Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody reactive with RNA polymerase III in systemic sclerosis.
    Okano Y; Steen VD; Medsger TA
    Ann Intern Med; 1993 Nov; 119(10):1005-13. PubMed ID: 8214977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis.
    Campochiaro C; Lytton S; Nihtyanova S; Fuchs D; Ong VH; Denton CP
    Clin Immunol; 2019 Feb; 199():18-24. PubMed ID: 30771500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
    Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
    J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.